1 study found for:    22422823 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: VELCADE (bortezomib);   Drug: dexamethasone;   Drug: cyclophosphamide;   Drug: Revlimid (lenalidomide)

Indicates status has not been verified in more than two years